(NP (NP (NNS Effects)) (PP (IN of) (NP (NN interleukin-10))) (PP (IN on) (NP (NP (JJ human) (JJ peripheral) (NN blood) (JJ mononuclear) (NN cell) (NNS responses)) (PP (TO to) (NP-COOD (NP (NN Cryptococcus) (NNS neoformans)) (, ,) (NP (NN Candida) (NNS albicans)) (, ,) (CC and) (NP (NN lipopolysaccharide)))))) (. .))
(S (NP-SBJ (NP (NN Deactivation)) (PP (IN of) (NP (JJ mononuclear) (NNS phagocytes)))) (VP-COOD (VP (VBZ is) (ADJP-PRD (JJ critical)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB limit) (NP (DT the) (JJ inflammatory) (NN response)))))) (CC but) (VP (MD can) (VP (VB be) (ADJP-PRD (JJ detrimental)) (PP (IN in) (NP (NP (DT the) (NN face)) (PP (IN of) (NP (JJ progressive) (NN infection)))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD compared) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT the) (VBG deactivating) (NN cytokine) (NP (NP (NN interleukin) (CD 10)) (PRN (-LRB- -LRB-) (NP (NN IL-10)) (-RRB- -RRB-))))) (PP (IN on) (NP (NP (JJ human) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-))) (NNS responses)) (PP (TO to) (NP-COOD (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-))) (, ,) (NP (NN Cryptococcus) (NNS neoformans)) (, ,) (CC and) (NP (NN Candida) (NNS albicans)))))))) (. .))
(S (NP-SBJ (NN IL-10)) (VP (VBD effected) (NP (NP (JJ dose-dependent) (NN inhibition)) (PP (IN of) (NP (NP (NP (NP (NN tumor) (NN necrosis) (NN factor) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-))) (NN release)) (PP (IN in) (NP (NP (NN PBMC)) (VP (VBN stimulated) (NP (-NONE- *)) (PP (IN by) (NP-LGS-COOD (NP (NN LPS)) (CC and) (NP (FW C.) (FW neoformans)))))))))) (, ,) (SBAR (IN with) (S-COOD (S (NP-SBJ-57 (JJ significant) (NN inhibition)) (VP (VBN seen) (NP (-NONE- *-57)) (PP (IN with) (NP (CD 0.1) (NN (ml U)))))) (CC and) (S (NP-SBJ-58 (NP (QP (JJR greater) (IN than) (CD 90)) (NN %)) (NP (NN inhibition))) (VP (VBN noted) (NP (-NONE- *-58)) (PP (IN with) (NP (CD 10) (NN (ml U))))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (PP (RB even) (IN at) (NP (NNS doses) (NP (QP (RB as) (JJ high) (IN as) (CD 100)) (NN (ml U))))) (, ,) (NP-SBJ (NN IL-10)) (VP (VBD inhibited) (NP (NN TNF-alpha) (NN release)) (PP (IN in) (NN response) (TO to) (NP (FW C.) (FW albicans))) (NP (IN by) (NP (QP (RB only) (CD 50)) (NN %)))) (. .))
(S (NP-SBJ (NN IL-10)) (ADVP (RB profoundly)) (VP (VBD inhibited) (NP (NP (NN release)) (PP (IN of) (NP (NN IL-1beta))) (PP (IN from) (NP (NP (NN PBMC)) (VP (VBN stimulated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (QP (DT all) (CD three)) (NNS stimuli)))))))) (. .))
(S (NP-SBJ-59 (NN TNF-alpha) (NN mRNA) (CC and) (NN release)) (VP (VBD was) (VP (VBN inhibited) (NP (-NONE- *-59)) (SBAR (RB even) (IN if) (S (NP-SBJ-60 (NN IL-10)) (VP (VBD was) (VP (VBN added) (NP (-NONE- *-60)) (PP-TMP (NP (QP (RP up) (TO to) (CD 8)) (NN h)) (IN after) (NP (JJ cryptococcal) (NN stimulation))))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NN inhibition)) (PP (IN of) (NP (NN IL-1) (NN beta) (NN mRNA)))) (VP-COOD (VP (VBD was) (PP-PRD (IN of) (NP (JJR lesser) (NN magnitude)))) (CC and) (VP (VBD occurred) (SBAR-TMP (WHADVP-61 (RB only) (WRB when)) (S (NP-SBJ-62 (NN IL-10)) (VP (VBD was) (VP (VBN added) (NP (-NONE- *-62)) (PP-TMP (IN within) (NP (NP (CD 2) (NN h)) (PP (IN of) (NP (JJ cryptococcal) (NN stimulation))))) (ADVP (-NONE- *T*-61)))))))) (. .))
(S (NP-SBJ (NN IL-10)) (VP (VBD inhibited) (NP (NP (NN translocation)) (PP (IN of) (NP (NN NF-kappaB)))) (PP (IN in) (NN response) (TO to) (NP-COOD (NP (NN LPS)) (CONJP (CC but) (RB not)) (NP (DT the) (JJ fungal) (NNS stimuli))))) (. .))
(S (NP-SBJ (DT All) (CD three) (NNS stimuli)) (VP (VBD induced) (NP (NP (NN IL-10) (NN production)) (PP (IN in) (NP (NN PBMC)))) (, ,) (SBAR (IN although) (S (NP-SBJ-63 (QP (IN over) (RB 10-fold) (JJR less)) (NN IL-10)) (VP (VBD was) (VP (VBN released) (NP (-NONE- *-63)) (PP (IN in) (NN response) (TO to) (NP (FW C.) (FW neoformans))) (PP (VBN compared) (PP (IN with) (NP-COOD (NP (NN LPS)) (CC and) (NP (NN C.) (NNS albicans)))))))))) (. .))
(S (ADVP (RB Thus)) (, ,) (SBAR (IN while) (S (NP-SBJ (NN IL-10)) (VP (VBZ has) (NP (VBG deactivating) (NNS effects)) (PP (IN on) (NP (NP (NN PBMC) (NNS responses)) (PP (TO to) (NP (QP (DT all) (CD three)) (NNS stimuli)))))))) (, ,) (NP-SBJ-64 (NP (JJ disparate) (ADJP-COOD (ADJP (NP (NN stimulus-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (JJ response-specific))) (NNS patterns)) (PP (IN of) (NP (NN deactivation)))) (VP (VBP are) (VP (VBN seen) (NP (-NONE- *-64)))) (. .))
(S (NP-SBJ-65 (NP (NN Inhibition)) (PP (IN by) (NP (NN IL-10))) (PP (IN of) (NP (JJ proinflammatory) (NN cytokine) (NN release)))) (VP (VBZ appears) (S (NP-SBJ (-NONE- *-65)) (VP (TO to) (VP-COOD (VP (VB occur) (PP-TMP-66 (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN gene) (NN transcription))))) (PP-67 (IN for) (NP (NN TNF-alpha)))) (CC and) (VP (ADVP-TMP-COOD=66 (CC both) (ADVP (RB transcriptionally)) (CC and) (ADVP (RB posttranscriptionally))) (PP=67 (IN for) (NP (NN IL-1beta)))))))) (. .))
